| 26 | | 5. [wiki: CCAP plenary, 24Jun20] **KL, All** |
| 27 | | - KL needs to add new participants to the relevant mailing lists. |
| 28 | | - Proposed talks: |
| 29 | | - Overview (Kurup) |
| 30 | | - Design of the accelerator facility (Pasternak) |
| 31 | | - Simulating the accelerator facility (Shields) |
| 32 | | - Simulating the end stations (Hughes) |
| 33 | | - Possibly something on target and capture (HTL, TSD, CW, to be decided). |
| 34 | | |
| 35 | | 6. Next steps: **All** |
| 36 | | - //To include discussion of development of proposal for 3-year R&D programme// |
| 37 | | - Unanimously agreed to prepare an application to the EPSRC Transformative Healthcare Technologies call. |
| 38 | | - KL will report detailed timeline as soon as it is known. |
| | 30 | 5. [wiki:Communication/Plenary/2020-06-24 CCAP plenary, 24Jun20]: **KL, All** |
| | 31 | |
| | 32 | 6. Status of preparation of Expression of Interest for the [https://epsrc.ukri.org/funding/calls/second-call-for-transformative-healthcare-technologies-pre-announcement-and-engagement-event/ EPSRC Transformative Healthcare Technologies call]: **KL, ALL** |
| | 33 | |
| | 34 | 7. Next steps: **All** |
| 44 | | |
| 45 | | == Agenda == |
| 46 | | |
| 47 | | 0. [raw-attachment:2020-06-09-Intro.pdf Introduction]: KL |
| 48 | | |
| 49 | | 1. [wiki:Research/DesignStudy/Meetings/2020/2020-06-02 Notes of previous meetings] and actions: |
| 50 | | * **KL**: Create draft response to referees. |
| 51 | | |
| 52 | | 2. Status of publication and pre-CDR: |
| 53 | | |
| 54 | | 3. Preparation of response to referees: **KL, ALL** |
| 55 | | |
| 56 | | 4. Updates: |
| 57 | | - Capture section: **CW** |
| 58 | | - Update on electrostatic simulation of Gabor lens: **TSD** |
| 59 | | - Simulation: |
| 60 | | - Particle production at laser target: **HTL** |
| 61 | | - Any other simulation |
| 62 | | |
| 63 | | 5. Plans for CCAP plenary, 24Jun20; **KL, JPa** |
| 64 | | |
| 65 | | 6. Next steps: **All** |
| 66 | | - //To include discussion of development of proposal for 3-year R&D programme// |
| 67 | | |
| 68 | | 7. AOB |
| 69 | | |
| 70 | | ---- |